IMNN•benzinga•
IMUNON To Present New Data From Phase 2 OVATION 2 Study Of IMNN-001, Investigational Therapy For Treatment Of Advanced Ovarian Cancer At 2025 ASCO Annual Meeting
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 23, 2025 by benzinga